Report 44: Recent trends in SARS-CoV-2 variants of concern in England

Autor: Mishra, S, Mindermann, S, Sharma, M, Whittaker, C, Mellan, T, Wilton, T, Klapsa, D, Mate, R, Fritzsche, M, Zambon, M, Ahuja, J, Howes, A, Miscouridou, X, Nason, G, Ratmann, O, Leech, G, Fabienne Sandkühler, J, Rogers-Smith, C, Vollmer, M, Unwin, H, Gal, Y, Chand, M, Gandy, A, Martin, J, Volz, E, Ferguson, N, Bhatt, S, Brauner, J, Flaxman, S

Since its emergence in Autumn 2020, the SARS-CoV-2 Variant of Concern (VOC) B.1.1.7 rapidly became the dominant lineage across much of Europe. Simultaneously, several other VOCs were identified globally. Unlike B.1.1.7, some of these VOCs possess mut

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b8f60139a5262082be3eeff19b0a59f
http://hdl.handle.net/10044/1/88876

Case report: Clearance of longstanding, immune-deficiency-associated, vaccine-derived polio virus infection following remdesivir therapy for chronic SARS-CoV-2 infection.

Autor: Bermingham WH; Department of Immunology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom., Canning B; Department of Virology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom., Wilton T; Division of Vaccines, National Institute for Biological Standards and Control, Medicines and Healthcare Products Regulatory Agency, Potters Bar, United Kingdom., Kidd M; Public Health Laboratory, UK Health Security Agency, Birmingham, United Kingdom., Klapsa D; Division of Vaccines, National Institute for Biological Standards and Control, Medicines and Healthcare Products Regulatory Agency, Potters Bar, United Kingdom., Majumdar M; Division of Vaccines, National Institute for Biological Standards and Control, Medicines and Healthcare Products Regulatory Agency, Potters Bar, United Kingdom., Sooriyakumar K; Department of Immunology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom., Martin J; Division of Vaccines, National Institute for Biological Standards and Control, Medicines and Healthcare Products Regulatory Agency, Potters Bar, United Kingdom., Huissoon AP; Department of Immunology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.

Publikováno v: Frontiers in immunology [Front Immunol] 2023 Mar 03; Vol. 14, pp. 1135834. Date of Electronic Publication: 2023 Mar 03 (Print Publication: 2023).

Sustained detection of type 2 poliovirus in London sewage between February and July, 2022, by enhanced environmental surveillance.

Autor: Klapsa D; Division of Vaccines, National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency, Potters Bar, UK., Wilton T; Division of Vaccines, National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency, Potters Bar, UK., Zealand A; Environmental Monitoring for Health Protection, Data, Analytics and Surveillance Group, UK Health Security Agency, Nobel House, London, UK., Bujaki E; Division of Vaccines, National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency, Potters Bar, UK., Saxentoff E; World Health Organization Regional Office for Europe, Regional Polio Laboratory Network, Copenhagen, Denmark., Troman C; Department of Infectious Disease Epidemiology, Imperial College London, London, UK., Shaw AG; Department of Infectious Disease Epidemiology, Imperial College London, London, UK., Tedcastle A; Division of Vaccines, National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency, Potters Bar, UK., Majumdar M; Division of Vaccines, National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency, Potters Bar, UK., Mate R; Division of Analytical and Biological Science, National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency, Potters Bar, UK., Akello JO; Department of Infectious Disease Epidemiology, Imperial College London, London, UK., Huseynov S; World Health Organization Regional Office for Europe, Regional Polio Laboratory Network, Copenhagen, Denmark., Zeb A; Environmental Monitoring for Health Protection, Data, Analytics and Surveillance Group, UK Health Security Agency, Nobel House, London, UK., Zambon M; National Polio Laboratory, Reference Services Division, UK Health Security Agency, London, UK., Bell A; North East and North Central London Health Protection Team, UK Health Security Agency, London, UK., Hagan J; World Health Organization Regional Office for Europe, Regional Polio Laboratory Network, Copenhagen, Denmark., Wade MJ; Environmental Monitoring for Health Protection, Data, Analytics and Surveillance Group, UK Health Security Agency, Nobel House, London, UK., Ramsay M; Immunisation and Vaccine Preventable Disease Division, UK Health Security Agency, London, UK., Grassly NC; Department of Infectious Disease Epidemiology, Imperial College London, London, UK., Saliba V; Immunisation and Vaccine Preventable Disease Division, UK Health Security Agency, London, UK., Martin J; Division of Vaccines, National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency, Potters Bar, UK. Electronic address: javier.martin@nibsc.org.

Publikováno v: Lancet (London, England) [Lancet] 2022 Oct 29; Vol. 400 (10362), pp. 1531-1538. Date of Electronic Publication: 2022 Oct 13.

Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing - Worldwide, March-October 2021.

Autor: Martin J, Burns CC, Jorba J, Shulman LM, Macadam A, Klapsa D, Majumdar M, Bullows J, Frolov A, Mate R, Bujaki E, Castro CJ, Bullard K, Konz J, Hawes K, Gauld J, Blake IM, Mercer LD, Kurji F, Voorman A, Diop OM, Oberste MS, Modlin J, Macklin G, Eisenhawer M, Bandyopadhyay AS, Zipursky S

Publikováno v: MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2022 Jun 17; Vol. 71 (24), pp. 786-790. Date of Electronic Publication: 2022 Jun 17.

Changing composition of SARS-CoV-2 lineages and rise of Delta variant in England.

Autor: Mishra S; Medical Research Council (MRC) Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, UK., Mindermann S; Oxford Applied and Theoretical Machine Learning (OATML) Group, Department of Computer Science, University of Oxford, UK., Sharma M; Department of Statistics, University of Oxford, UK.; Department of Engineering Science, University of Oxford, UK.; Future of Humanity Institute, University of Oxford, UK., Whittaker C; Medical Research Council (MRC) Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, UK., Mellan TA; Medical Research Council (MRC) Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, UK., Wilton T; National Institute for Biological Standards and Control (NIBSC), UK., Klapsa D; National Institute for Biological Standards and Control (NIBSC), UK., Mate R; National Institute for Biological Standards and Control (NIBSC), UK., Fritzsche M; National Institute for Biological Standards and Control (NIBSC), UK., Zambon M; Public Health England, London, UK., Ahuja J; Future of Humanity Institute, University of Oxford, UK.; Medical Sciences Division, University of Oxford, UK., Howes A; Department of Mathematics, Imperial College London, UK., Miscouridou X; Department of Mathematics, Imperial College London, UK., Nason GP; Department of Mathematics, Imperial College London, UK., Ratmann O; Department of Mathematics, Imperial College London, UK., Semenova E; Department of Mathematics, Imperial College London, UK., Leech G; Department of Computer Science, University of Bristol, UK., Sandkühler JF; Department of Psychology, University of Bonn, Germany., Rogers-Smith C; OATML Group (work done while at OATML as an external collaborator), Department of Computer Science, University of Oxford, UK., Vollmer M; Medical Research Council (MRC) Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, UK.; Public Health England, London, UK., Unwin HJT; Medical Research Council (MRC) Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, UK., Gal Y; Oxford Applied and Theoretical Machine Learning (OATML) Group, Department of Computer Science, University of Oxford, UK., Chand M; Public Health England, London, UK., Gandy A; Department of Mathematics, Imperial College London, UK., Martin J; National Institute for Biological Standards and Control (NIBSC), UK., Volz E; Medical Research Council (MRC) Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, UK., Ferguson NM; Medical Research Council (MRC) Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, UK., Bhatt S; Medical Research Council (MRC) Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, UK.; Section of Epidemiology, Department of Public Health, University of Copenhagen, Denmark., Brauner JM; Oxford Applied and Theoretical Machine Learning (OATML) Group, Department of Computer Science, University of Oxford, UK.; Future of Humanity Institute, University of Oxford, UK., Flaxman S; Department of Mathematics, Imperial College London, UK.

Publikováno v: EClinicalMedicine [EClinicalMedicine] 2021 Jul 31; Vol. 39, pp. 101064. Date of Electronic Publication: 2021 Jul 31 (Print Publication: 2021).